Tele-rehabilitation in Chronic Respiratory Disease: an Observational Cohort Study
NCT ID: NCT05820776
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2023-04-06
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases
NCT05824910
Pulmonary Rehabilitation at Home Versus at the Gymnasium
NCT00169897
Home-based Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
NCT04722224
Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study
NCT04658979
TeleRehabilitation for Patients With Chronic Respiratory Failure.
NCT04566523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulmonary rehabilitation
The intervention is PR delivered via a telemedicine. The intervention is PR delivered via a telemedicine. The program is delivered by the multidisciplinary via a remote application for two sessions per week for ten weeks. Remotely supervised exercise includes: 1) deep breathing reinforcing pursed lip and diaphragmatic breathing; 2) warm up breathing and stretching exercise; 3) a cardiorespiratory aerobic exercise battery; 4) resistance training, and; stretching cool down. There is also an educational component. The secondary (maintenance) program includes ongoing remotely supervised exercise and education once a week for six months (24 sessions). All patients successfully completing the initial PR are offered the maintenance program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* qualified candidates for pulmonary rehabilitation,
* current non-smoker;
* primary diagnosis chronic respiratory disease limited by dyspnea (mMRC≥2);
* free of exacerbation at the time of admission, and
* stable co-existing conditions
Exclusion Criteria
* being unable to communicate with the treating team.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West Park Healthcare Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roger Goldstein
Director, Program in Respiratory Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roger Goldstein, MD
Role: PRINCIPAL_INVESTIGATOR
West Park Healthcare Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Park Healthcare Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Office Supervisor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Research Assistant
Role: primary
Office Supervisor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTR-RG2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.